You are here

Amgen

2012 Preview: Cancer Immunotherapy Catalysts

Seeking Alpha

Thu, 12/15/11 - 12:08 pm

Bristol-Myers Squibb

Idera Pharmaceuticals

NewLink Genetics

Amgen More Undervalued Than Johnson & Johnson

Seeking Alpha

Sun, 12/11/11 - 02:45 pm

Amgen expects to acquire 83.3M shares in buyback

Yahoo/AP

Thu, 12/8/11 - 11:25 am

Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug

Bloomberg

Mon, 12/5/11 - 01:34 pm

chronic kidney disease

December Catalysts for Drug and Biotech Stocks

Minyanville

Sat, 12/3/11 - 11:11 am

Aveo Pharmaceutical

ONYX Pharmaceuticals

Seattle Genetics

5 Risky Biotechs With Serious Profit Potential

Seeking Alpha

Tue, 11/29/11 - 01:37 pm

Spectrum Pharmaceuticals

New Patent Could Be Worth $6 A Share To Amgen

Forbes

Mon, 11/28/11 - 09:55 am

rheumatoid arthritis

Looking back at Immunex and ahead to Seattle's biotech future

bizjournals.com

Sat, 11/26/11 - 10:15 am

Amgen's new Enbrel patent could delay biosims for 17 years

Fierce Pharma

Wed, 11/23/11 - 01:11 pm

anti-inflammatory

Amgen Says It Signed Seven-Year Epogen Sales Agreement With DaVita

Bloomberg

Sat, 11/19/11 - 11:33 am

Regeneron And Amgen: More Breakthrough Drugs On The Horizon

Seeking Alpha

Fri, 11/18/11 - 11:45 am

PCSK9 inhibitor

Has Amgen crossed into Big Pharma territory?

Fierce Pharma

Mon, 11/14/11 - 05:20 pm

Let's Check Amgen's Growth

Motley Fool

Sun, 11/13/11 - 12:07 pm

Amgen To Trade Ex-Dividend

Forbes

Sat, 11/12/11 - 12:19 pm

U.S. court allows class action suit against Amgen

Reuters

Wed, 11/9/11 - 12:08 pm

Class Action Lawsuit

Amgen Stock Rises on New Buyback Plan, But How About the Debt?

Barron's

Mon, 11/7/11 - 09:13 pm

Amgen jumps 5% on $5 billion stock buy-back

Marketwatch

Mon, 11/7/11 - 11:55 am

Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients With Moderately Active Disease

Yahoo/PR NewsWire

Sun, 11/6/11 - 12:01 pm

rheumatoid arthritis

Pages